Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.6 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |